Trials / Sponsors / Kira Pharmacenticals (US), LLC.
Kira Pharmacenticals (US), LLC.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangi Systemic Lupus Erythematosus | Phase 2 | 2025-03-01 |
| Not Yet Recruiting | Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis Glomerulonephritis | Phase 2 | 2025-03-01 |
| Active Not Recruiting | To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104 Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | 2022-11-25 |
| Completed | To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Paroxysmal Nocturnal Hemoglobinuria | Phase 1 | 2020-12-30 |